Evolution of the Average Target: Docebo Inc.

Evolution of the Target Price: Docebo Inc.

Changes in Analyst Recommendations: Docebo Inc.

6.YCsEjeLS4Gbpb4OWs_xiLwYkwU3jVOV-47N-Xo3Qjd4.K1Mx4JSIqhSlVtva-KYxa2lwux2bbNYniMUEa-mb7qshb33Vm5SUEJpW2g~fe7dfc45b3945fd134ccd83c62a3040d
04-23 CIBC Confirms Outperformer Rating and Target of US$28 on Docebo After Inspire 2026 Conference MT
04-22 Stifel Canada Sees Potential Upside For Docebo MT
04-17 CIBC Lowers Price Target on Software and Services Stocks MT
01-30 CIBC Confirms Outperformer Rating on Docebo and Raises Target to US$34.00 MT
01-21 Stifel Canada on Docebo Acquiring 365Talents MT
01-21 CIBC Maintained Its Outperformer Rating on Docebo As It Acquires 365Talents MT
12-15 CIBC's Top Picks For 2026 Software Sector MT
12-15 CIBC's Top Picks For 2026 Software Sector MT
11-07 Docebo Brief: Revising Financial Guidance for Fiscal Year ended December 31, 2025 MT
11-05 Oppenheimer Initiates Coverage on Docebo With Outperform Rating, CA$49.38 Price Target MT
25-06-09 Cantor Fitzgerald Initiates Docebo at Overweight With CA$47.85 Price Target MT
25-05-12 Docebo Shares Lower After Morgan Stanley Downgrade MT
25-05-12 Morgan Stanley Downgrades Docebo to Equalweight From Overweight After 'Disappointing' Q1 Update, Cuts Price Target to $32 From $41 MT
25-05-12 National Bank Downgrades Docebo to Sector Perform From Outperform, Adjusts Price Target to $35 From $45 MT
25-04-08 National Bank Says Docebo Promoting Farber to CFO is "Not Surprising" MT
25-03-03 Docebo Upgraded to Outperform at ATB MT
24-10-21 CIBC Raises Price Target on Six Software and Services Companies MT
24-05-13 Needham Adjusts Price Target on Docebo to $45 From $63, Keeps Buy Rating MT
24-04-19 Morgan Stanley Trims Price Target on Docebo to $65 From $67, Keeps Overweight Rating MT
24-02-26 Scotiabank Raises Docebo's Price Target to $65 From $60, Keeps Sector Outperform Rating MT
24-02-26 Morgan Stanley Adjusts Price Target on Docebo to $67 From $63, Keeps Overweight Rating MT
23-12-22 Morgan Stanley Boosts Price Target on Docebo to $63 From $53, Keeps Overweight Rating MT
23-11-23 Docebo Maintained at Buy at Stifel GMP Following C-Suite Changes; Price Target Raised to US$60.00 MT
23-11-14 Needham Starts Docebo With Buy Rating, Price Target is $56 MT
23-11-10 Goldman Sachs Raises Price Target on Docebo to $44 From $39, Maintains Neutral Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+42.55%
+37.15%
+3.59%
-0.64%
+24.98%
+2.99%
+61.84%
+21.37%
+31.36%
Average +25.02%
Weighted average by Cap. +38.28%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
17.33USD
Average target price
26.30USD
Spread / Average Target
+51.77%
High Price Target
26.30USD
Spread / Highest target
+51.77%
Low Price Target
26.30USD
Spread / Lowest Target
+51.77%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Oppenheimer
Cantor Fitzgerald
Morgan Stanley
National Bank
ATB Capital
Needham & Co.
Scotiabank
Stifel GMP
Goldman Sachs
National Bank Financial
Canaccord Genuity
Stifel Nicolaus
Berenberg Bank
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
17.33USD
Average target price
26.30USD
Spread / Average Target
+51.77%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!